BioSpace News Archive

Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB:NPTX), today announces that its wholly owned subsidiary, Kannalife Sciences, Inc. has received a notice of award from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) for a $2.97 million Phase 2 STTR Study Grant.

Lantern Pharma (NASDAQ: LTRN), and Deep Lens, today announced that they have entered into a strategic collaboration that will leverage Deep Lens’ artificial intelligence clinical trial matching solution, VIPERÔ.

BioSymetrics, an AI-powered drug discovery company, today announced the appointments of Stacie Calad-Thomson as Chief Strategy Officer and Head of Drug Discovery, Matt Fusco as Chief Operating Officer, and Amanda Guisbond as Vice President of Marketing and Communications.

Adial Pharmaceuticals, Inc. today announced that Purnovate has entered into a research agreement with Dr. Mark Roeser from the University of Virginia School of Medicine to develop new formulations of the Company’s proprietary adenosine compounds for wound healing through transdermal administration (i.e., through the skin).

Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate

Stair lift, commonly used in home care settings or healthcare facilities, are motorized seats which run along a rail or track and are powered by alternating current or batteries so that they can function even during power outages.

Myelofibrosis is an uncommon type of bone marrow cancer and is related to a group of blood cancers known as myeloproliferative neoplasms.

Liver carries out important functions in the body such as protein production, metabolizing of fat & carbohydrate, and detoxification of drugs, alcohol, and environmental toxin.

Fact.MR – A Market Research and Competitive Intelligence Provider: Fact.MR in its latest market analysis forecasts that the cardiac ablation technologies market will register high growth during the forecast period.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global benzodiazepine drugs market is set to register steady growth during the forecast period between 2020 and 2026.